James Loerop
Executive Vice President, Business Development and Strategic Planning
Other
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Aclaris Therapeutics, Inc. (ACRS) | Chief Business Officer | $416,000 | $1,447,106 |
| 2023 | Aclaris Therapeutics, Inc. (ACRS) | Chief Business Officer | $435,000 | $2,332,912 |
| 2022 | Anika Therapeutics, Inc. (ANIK) | former EVP, Business Development and | $36,454 | $73,617 |
| 2021 | Anika Therapeutics, Inc. (ANIK) | former EVP, Business Development and | $394,900 | $874,404 |
| 2020 | Anika Therapeutics, Inc. (ANIK) | EVP, Business Development and Strategic Planning | $381,563 | $1,039,871 |
| 2019 | Anika Therapeutics, Inc. (ANIK) | EVP, Business Development and Strategic Planning | $165,865 | $1,479,626 |
| 2018 | Anika Therapeutics, Inc. (ANIK) | EVP, Business Development and Strategic Planning | — | — |
Earnings-call appearances
No earnings-call appearances recorded yet.